
Immunotherapy combined with chemotherapy has significantly improved outcomes for patients with advanced or recurrent endometrial cancer, offering substantial survival benefits across different molecular subtypes.


coremsg

Drs Ursula A. Matulonis and Mansoor Mirza discuss immunotherapy trials, novel therapies such as CDK4/6 inhibitors and antibody-drug conjugates, and shared decision-making.

Episode 5: Immunotherapy and Advanced Endometrial Cancer

immunotherapy-transforming-treatment-of-advanced-endometrial-cancer-insights-from-leading-expert


Immunotherapy Transforming Treatment of Advanced Endometrial Cancer: Insights from Leading Expert
